Skip to main content
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Beakers with MJFF logos

    MJFF Scientist Among Featured Speakers at Neurodegenerative Drug Development Summit

    MJFF staff scientist Samantha Hutten, PhD, will join a distinguished roster of presenters at the 8th Annual Neurodegenerative Drug Development Summit February 25-27 in Boston.

  • a_synuclein

    Wave of Parkinson’s Research Updates: New Findings and Studies

    In conjunction with a major health care conference, companies release positive trial results and plans to advance studies including one for sleep problems.

  • Doctor with tablet.

    MJFF and Sage Bionetworks Launch Data Challenge

    BEAT-PD is a data challenge designed to benchmark new methods to predict Parkinson’s disease progression. 

  • Close up of hand holding test tube

    What We Fund: $15 Million in New Grants for Parkinson’s Research

    Foundation-funded research lays groundwork to deepen understanding of Parkinson's and speed breakthroughs.

  • Four beakers lined up on a table in a lab.

    FDA Reviewing New Treatment for “Off” Episodes

    Sunovion Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration accepted its New Drug Application for apomorphine sublingual film.

  • Scientist in Lab

    PPMI Dispatch: Streamlined Data, Genetic Indicators and Cognitive Decline Predictors

    Data from the Parkinson’s Progression Markers Initiative has been downloaded more than 5 million times. View recent findings and updates from the study.

Gloved hand holding research samples.

Be Part of the Answer

You have the power to impact your future and the future of millions living with Parkinson's disease. Explore clinical research participation today.

Join a Study
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.